News

Read about a recent development which has further amplified our longstanding campaign to improve access to the Free Travel scheme for people with epilepsy.

The Annual General Meeting of Brainwave, The Irish Epilepsy Association (trading as Epilepsy Ireland) for the year ending 31.12.22 was held on July 6th via zoom.

Last week, the Government approved the holding of an inquiry into the historical licensing and prescribing of Sodium Valproate. Read our response to this important development.

A study recently published in the medical journal Neuron, has providing further information on how cannabidiol (CBD) works to potentially prevent seizures.

CBD is a non-psychoactive component of the cannabis plant, meaning that it does not cause the ‘high’ associated with recreational use of cannabis. In recent years, numerous studies have been carried out on the use of CBD treatments in drug-resistant epilepsies – many of which have showed positive findings. 

Learn more about a rare type of epilepsy on Dravet Syndrome Awareness day.

A study from Germany has reported a number of interesting insights when it comes to the discussion of Sudden Unexpected Death in Epilepsy with people with epilepsy.

With the fund set to benefit over 1.2 million children nationally, we are delighted that the importance of supporting children with epilepsy has been recognised under the #ToyShowAppeal!

Read our report on our activities throughout 2022.

Read the latest update in our efforts to improve access to the Free Travel scheme for people with epilepsy.

Read our annual 'Use of Funds' statement for 2022, which outlines to our members, service users, volunteers, supporters, donors, and the public how we raise and use our income at Epilepsy Ireland.